Lijuan Zhou

发表

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

D. Su, Xiaoqing Shi, Yi-Ran Cai, 2019, BMC Cancer.

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

D. Su, Yi-Ran Cai, Minghuan Yang, 2020 .

不同基因分型晚期非小细胞肺癌患者的预后分析

Quan Zhang, Shucai Zhang, Jinghui Wang, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer

Quan Zhang, D. Su, M. Jin, 2017, Scientific Reports.

Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes.

D. Su, Yi-Ran Cai, Yujie Dong, 2016, Oncology letters.

Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.

Da-ping Yu, D. Su, Dan Zhao, 2014, Biomedical reports.

Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements

Shucai Zhang, D. Su, Jinghui Wang, 2015, Thoracic cancer.

Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring ALK Rearrangements Detected by FISH, IHC, and RT-PCR

Shucai Zhang, D. Su, Zongde Zhang, 2014, PloS one.

肺腺癌EGFR与KRAS基因突变状态分析

Quan Zhang, Shucai Zhang, Jinghui Wang, 2015, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study

Lixin Wei, D. Su, N. Che, 2015, Tumor Biology.

Clinicopathologic characteristics of ALK rearrangements in primary lung adenocarcinoma with identified EGFR and KRAS status

Quan Zhang, Shucai Zhang, D. Su, 2014, Journal of Cancer Research and Clinical Oncology.

Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas

D. Su, Yi-Ran Cai, Yujie Dong, 2016, Scientific Reports.

Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.

D. Su, Yi-Ran Cai, J. Mu, 2016, Oncology letters.

MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.

Honggang Liu, N. Che, Dan Zhao, 2020, Japanese journal of clinical oncology.

The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma

Lixin Wei, D. Su, N. Che, 2015, Tumor Biology.

The significance of Siglec-15 expression in resectable non-small cell lung cancer.

J. Lin, D. Su, N. Che, 2020, Neoplasma.

Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma.

Zichen Liu, Kun Li, Yujie Dong, 2024, Journal of clinical pathology.